October 11, 2024
Washington and 16 other states with Democratic attorneys general are pressing a federal judge to force the U.S. Food and Drug Administration to lift restrictions on access to mifepristone, arguing that the agency is swayed by the controversy swirling around the abortion medication that has been proved to be safer than Tylenol, Viagra and insulin.
July 24, 2024
The Ninth Circuit rejected a bid by Idaho and other Republican-led states to intervene in Washington's lawsuit seeking to expand access to the abortion pill mifepristone, ruling Wednesday the states lacked standing and only speculated about how they were injured.
March 13, 2024
Two Ninth Circuit judges on Wednesday challenged Idaho and other Republican-led states' bid to intervene in Washington's lawsuit seeking to expand access to the abortion pill mifepristone, asking if the states could back up their claims of economic harm.
June 22, 2023
The U.S. Supreme Court's elimination of the constitutional right to abortion hit like an earthquake last summer, uprooting long-standing reproductive rights, triggering state laws curbing abortion access and flooding courts with litigation. A year later, legal battles promise further shake-ups to the abortion landscape.
April 24, 2023
A Washington federal judge has rejected a bid by Idaho and six other Republican-leaning states to join Washington's lawsuit challenging federal restrictions on the abortion pill mifepristone, ruling the case won't impair those states' ability to enforce their own state laws regulating medication abortion.
April 14, 2023
The U.S. Food and Drug Administration joined states led by Washington to urge a federal judge not to allow Idaho and a handful of Republican-led states to join a lawsuit challenging federal restrictions on the abortion pill mifepristone.
April 10, 2023
The U.S. Department of Justice told the Fifth Circuit on Monday that the anti-abortion groups and physicians who sued to undo the U.S. Food and Drug Administration's 23-year-old approval of the abortion pill mifepristone lack standing and urged the court to halt a Texas federal judge's order blocking medication abortion access nationwide starting Friday.
April 10, 2023
Chief executive officers and top legal counsel for pharmaceutical and biotech companies, including Pfizer, said a Texas federal judge's Friday order blocking the effective date of the U.S. Food and Drug Administration's decades-old approval of the abortion drug mifepristone fundamentally undermines the agency's authority and threatens industry.
April 07, 2023
A Texas federal judge Friday blocked the effective date of the U.S. Food and Drug Administration's decades-old approval of the abortion drug mifepristone and gave the Biden administration one week to appeal, drawing out a watershed ruling that could dramatically restrict abortion access in the U.S., where medication abortion has become the most common method to terminate pregnancies.
March 20, 2023
The U.S. Food and Drug Administration told a Washington federal court that Democratic state attorneys general waited for more than two decades to challenge restrictions on abortion medication mifepristone, which in fact the agency has just loosened.